US Democrat Senators call for $25 billion coronavirus vaccine funding

15 July 2020

In the USA, Senate Minority Leader Charles Schumer (Democrat: New York) and Senator Patty Murray (Democrat: Washington), the top Democrat on the Senate Health Committee, released a white paper on Monday saying the Trump Administration needs to do more to ensure safe and effective vaccines for the fight against the novel coronavirus pandemic sweeping the country.

They are calling for $25 billion in funding to be included in the next coronavirus response package, expected to be put together later this month, as well as policy changes.

The lawmakers say the COVID-19 poses an unprecedented threat to public health - in the mere months since SARSCoV-2, the virus that causes COVID-19, was detected in the USA, more than 3.2 million individuals have been diagnosed with COVID-19 and over 135,000 people have died in the USA.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK